New Oral Weight-Loss Pill Outperforms Semaglutide in Major Clinical Trial

A new once-daily oral medication called orforglipron has outperformed oral semaglutide in a major clinical trial, offering superior weight loss…

Submit Your Paper to GMJ

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

Extra Virgin Olive Oil’s Grade Doesn’t Measure What Matters: Why Polyphenol Content Goes Unlabelled

The International Olive Council's "extra virgin" grade measures chemical damage, not polyphenol content—the bioactive responsible for olive oil's cardiovascular benefits.…

L-Theanine Shifts Brain Waves Toward Calm Focus Without Sedation, Research Shows

L-theanine, an amino acid in green tea, promotes calm alertness by shifting brain waves toward alpha (relaxed focus) while reducing…

Animal Protein’s Muscle-Building Edge Disappears When Measured Over Days, Not Hours

A 2023 study found that animal protein triggers 47% higher muscle protein synthesis after a single meal—but this advantage vanishes…

Mitochondrial metabolism reshapes immunity, stem cells, and tumour development

Mitochondrial TCA cycle intermediates function as master regulators of immune responses, stem cell fate, and tumour development. Supporting mitochondrial health…

How B Vitamins and Micronutrients Protect Brain Function: Evidence from Neuroscience

B vitamins regulate homocysteine, fuel mitochondrial energy production, and synthesize mood-regulating neurotransmitters—three mechanisms critical for cognitive protection. Evidence shows that…

Three-quarters of the world falls short on omega-3: why 250 mg daily is not optional

A global review of nutrition guidelines shows that 76% of the world's population fails to meet the minimum recommended intake…

How your body’s metabolic pathways control energy, mood, and health

Your body uses a unified metabolic system where carbohydrates, fats, and proteins all converge into shared pathways that determine energy,…

MTHFR Gene Variant and Riboflavin: Why B2 Matters More Than Methylfolate Hype

Clinical trials show that MTHFR C677T TT carriers with hypertension respond to low-dose riboflavin (1.6 mg/day) with 13 mmHg systolic…

GMJ BriefsView all →
© 2026 GMJ News · PHIG · Sheni Network